港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

和譽-B

12.230

-0.280-2.24%

成交量：106.07萬

成交額：1,300.49萬

市值：82.19億

市盈率：121.62

高：12.740

開：12.510

低：11.940

收：12.510

52周最高：19.780

52周最低：5.520

股本：6.72億

香港流通股本：6.72億

量比：0.70

換手率：0.16%

股息：- -

股息率：- -

每股收益(LYR):0.101

淨資產收益率：2.85%

總資產收益率：0.78%

市淨率：3.76

市盈率(LYR):121.62

市銷率: 11.81

資料載入中...

總覽公司新聞資訊公告

和譽-B(02256)：FGFR2/3抑制劑ABSK061 獲FDA授予孤兒藥資格認定用於治療軟骨發育不全

和譽-B(02256)：依帕戈替尼聯合靶免療法一線治療晚期肝細胞癌完成 II期臨床首例患者給藥

和譽－Ｂ(02256)股價下跌5.11%，現價港幣$12.07

阿斯达克财经

每日沽空追蹤 | 和譽-B 03月11日沽空量成交6.3萬股，沽空比例為2.44%

和譽-B03月11日主力淨流出177.5萬元散户資金買入

和譽(02256.HK)用於治療軟骨發育不全藥品ABSK061獲藥物資格認定

阿斯达克财经

和譽-B(02256)：FGFR2/3抑制劑ABSK061獲FDA授予罕見兒科疾病藥物資格認定

港股異動 | 和譽-B(02256)再升逾9% 貝捷邁全球III期MANEUVER研究結果榮登《柳葉刀》

智通财经网

異動解讀 | 利好出盡，和譽-B盤中大跌6.14%

和譽-B(02256)：《柳葉刀》(The Lancet)發布貝捷邁®全球III期MANEUVER研究結果

和譽-B（02256）2026年2月股份變動月報：股本維持穩定

每日沽空追蹤 | 和譽-B 03月05日沽空量成交7.8萬股，沽空比例為3.6%

和譽-B午前漲逾5% 公司連續第二年實現盈利

異動解讀 | 和譽-B盤中大漲6.08%，受益於連續盈利及核心產品商業化強勁預期

【券商聚焦】國元證券：港股市場震盪上行，關注創新藥及黃金板塊

異動解讀 | 和譽-B盤中大漲5.83%，KRAS抑制劑臨床試驗獲進展及主席增持提振信心

和譽-B(02256)：和譽醫藥口服小分子KRAS G12D抑制劑 ABSK141完成首例患者給藥

和譽-B(02256)獲創始人、執行董事、首席執行官兼董事會主席徐耀昌增持公司4.5萬股

和譽-B首席執行官於公開市場增持4.5萬股，每股均價11.26港元

異動解讀 | 和譽-B盤中大跌5.56%，業績全面收益下滑及高管變動引發市場擔憂

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02256/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02256","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和譽-B","latestPrice":12.23,"timestamp":1773907695003,"preClose":12.51,"halted":0,"volume":1060721,"delay":0,"changeRate":-0.022382094324540316,"floatShares":672000000,"shares":672000000,"eps":0.10055907911268468,"marketStatus":"未開盤","change":-0.28,"latestTime":"03-19 16:08:15","open":12.51,"high":12.74,"low":11.94,"amount":13004925,"amplitude":0.063949,"askPrice":12.26,"askSize":7000,"bidPrice":12.21,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.10346754030047155,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1773970200000},"marketStatusCode":0,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":12.51,"openAndCloseTimeList":[[1773883800000,1773892800000],[1773896400000,1773907200000]],"volumeRatio":0.704154,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","floatShares":672000000,"roa":"0.78%","roe":"2.85%","lyrEps":0.100559,"volumeRatio":0.704154,"shares":672000000,"dividePrice":0,"high":12.74,"amplitude":0.063949,"preClose":12.51,"low":11.94,"week52Low":5.52,"pbRate":"3.76","psRate":"11.81","week52High":19.78,"institutionHeld":0,"latestPrice":12.23,"committee":-0.75,"eps":0.10055907911268468,"divideRate":0,"volume":1060721,"delay":0,"ttmEps":0.10346754030047155,"open":12.51,"prevYearClose":13.01,"prevWeekClose":12.12,"prevMonthClose":12.71,"prevQuarterClose":13.01,"fiveDayClose":12.4,"twentyDayClose":13.18,"sixtyDayClose":13.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02256\",params:#limit:5,,,undefined,":[{"date":"2026-03-02","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772415000000,"name":null,"time":"","dateTimestamp":1772380800000,"actualEps":null},{"date":"2025-08-04","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754271000000,"name":null,"time":"","dateTimestamp":1754236800000,"actualEps":null},{"date":"2025-03-03","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740965400000,"name":null,"time":"盤後","dateTimestamp":1740931200000,"actualEps":null},{"date":"2024-08-12","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723426200000,"name":null,"time":"盤後","dateTimestamp":1723392000000,"actualEps":null},{"date":"2024-03-12","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710207000000,"name":null,"time":"","dateTimestamp":1710172800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02256\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02256\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1762272000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02256\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02256","date":"2026-03-18","current":118.201322,"percent":0.905591,"low":-234.512257,"twenty":-4.869572,"median":-1.501288,"eighty":54.371907,"high":254.727882,"avg":5.905884,"sd":82.783622,"marketCap":8411240488},"quantilePoints":[{"date":"2021-10-15","current":-9.313928,"twenty":-4.877635,"median":-1.919564,"eighty":-1.91666,"marketCap":8710582740},{"date":"2021-10-22","current":-8.650919,"twenty":-8.878249,"median":-8.660561,"eighty":-1.919672,"marketCap":8148609660},{"date":"2021-10-29","current":-8.806935,"twenty":-8.825514,"median":-8.653413,"eighty":-5.845693,"marketCap":8275053603},{"date":"2021-11-05","current":-9.301473,"twenty":-9.072506,"median":-8.661255,"eighty":-8.486758,"marketCap":8754126241},{"date":"2021-11-12","current":-8.237331,"twenty":-8.927135,"median":-8.653413,"eighty":-8.255925,"marketCap":7784568118},{"date":"2021-11-19","current":-7.891647,"twenty":-8.895236,"median":-8.502762,"eighty":-8.001626,"marketCap":7447330510},{"date":"2021-11-26","current":-7.829582,"twenty":-8.864707,"median":-8.396384,"eighty":-7.827763,"marketCap":7391124242},{"date":"2021-12-03","current":-7.421405,"twenty":-8.825514,"median":-8.237331,"eighty":-7.536645,"marketCap":7018757716},{"date":"2021-12-10","current":-6.897038,"twenty":-8.719527,"median":-8.053855,"eighty":-7.419956,"marketCap":6533978655},{"date":"2021-12-17","current":-6.835017,"twenty":-8.660839,"median":-7.891647,"eighty":-7.035882,"marketCap":6470746603},{"date":"2021-12-24","current":-6.74694,"twenty":-8.657769,"median":-7.827308,"eighty":-6.929689,"marketCap":6393462985},{"date":"2021-12-31","current":-6.732295,"twenty":-8.653912,"median":-7.658199,"eighty":-6.817054,"marketCap":6393462985},{"date":"2022-01-07","current":-6.564869,"twenty":-6.733406,"median":-6.682233,"eighty":-6.545813,"marketCap":6210792614},{"date":"2022-01-14","current":-5.928147,"twenty":-6.714875,"median":-6.541049,"eighty":-6.306527,"marketCap":5620626800},{"date":"2022-01-21","current":-5.914607,"twenty":-6.690644,"median":-6.454435,"eighty":-5.918405,"marketCap":5620626800},{"date":"2022-01-28","current":-5.774086,"twenty":-6.634775,"median":-6.223148,"eighty":-5.77564,"marketCap":5473085346},{"date":"2022-02-04","current":-5.576691,"twenty":-6.603137,"median":-6.042935,"eighty":-5.774086,"marketCap":5283389192},{"date":"2022-02-11","current":-4.350779,"twenty":-6.564869,"median":-5.916505,"eighty":-5.570983,"marketCap":4130278698},{"date":"2022-02-18","current":-4.318127,"twenty":-6.517229,"median":-5.781336,"eighty":-4.350779,"marketCap":4119415434},{"date":"2022-02-25","current":-3.815851,"twenty":-6.456658,"median":-5.774086,"eighty":-4.326746,"marketCap":3649226620},{"date":"2022-03-04","current":-3.520975,"twenty":-6.454435,"median":-5.57398,"eighty":-4.051501,"marketCap":3368516880},{"date":"2022-03-11","current":-3.085511,"twenty":-6.318497,"median":-5.537277,"eighty":-3.823357,"marketCap":2947452270},{"date":"2022-03-18","current":-1.525941,"twenty":-6.288573,"median":-4.578518,"eighty":-3.682078,"marketCap":3396587854},{"date":"2022-03-25","current":-1.443908,"twenty":-6.157723,"median":-4.346691,"eighty":-3.085511,"marketCap":3214126523},{"date":"2022-04-01","current":-1.328833,"twenty":-5.928147,"median":-4.322437,"eighty":-2.968177,"marketCap":2961487757},{"date":"2022-04-08","current":-1.375471,"twenty":-5.921366,"median":-4.242175,"eighty":-1.521815,"marketCap":3066753909},{"date":"2022-04-14","current":-1.437651,"twenty":-5.917771,"median":-4.006843,"eighty":-1.445834,"marketCap":3200091036},{"date":"2022-04-22","current":-1.465035,"twenty":-5.915746,"median":-3.893702,"eighty":-1.44567,"marketCap":3200091036},{"date":"2022-04-29","current":-1.247364,"twenty":-5.863479,"median":-3.81646,"eighty":-1.439188,"marketCap":2680778017},{"date":"2022-05-06","current":-1.254519,"twenty":-5.784606,"median":-3.815709,"eighty":-1.377501,"marketCap":2673760273},{"date":"2022-05-13","current":-1.307549,"twenty":-5.775886,"median":-3.520975,"eighty":-1.375471,"marketCap":2736919965},{"date":"2022-05-20","current":-1.23325,"twenty":-5.775272,"median":-3.089354,"eighty":-1.329109,"marketCap":2617618325},{"date":"2022-05-27","current":-1.250867,"twenty":-5.774086,"median":-3.004697,"eighty":-1.3182,"marketCap":2652707043},{"date":"2022-06-02","current":-1.316602,"twenty":-5.762384,"median":-2.968177,"eighty":-1.30953,"marketCap":2807097400},{"date":"2022-06-10","current":-1.15651,"twenty":-5.613245,"median":-2.229502,"eighty":-1.30593,"marketCap":2449192481},{"date":"2022-06-17","current":-1.078161,"twenty":-5.572353,"median":-1.465035,"eighty":-1.267614,"marketCap":2280766637},{"date":"2022-06-24","current":-1.093711,"twenty":-5.57104,"median":-1.447186,"eighty":-1.255725,"marketCap":2322873098},{"date":"2022-06-30","current":-1.184967,"twenty":-5.550759,"median":-1.445752,"eighty":-1.244028,"marketCap":2512352173},{"date":"2022-07-08","current":-1.296171,"twenty":-5.113983,"median":-1.443908,"eighty":-1.246415,"marketCap":2750955452},{"date":"2022-07-15","current":-1.341671,"twenty":-4.816469,"median":-1.4094,"eighty":-1.249466,"marketCap":2821132887},{"date":"2022-07-22","current":-1.367474,"twenty":-4.53297,"median":-1.376774,"eighty":-1.253058,"marketCap":2877274835},{"date":"2022-07-29","current":-1.365808,"twenty":-4.349713,"median":-1.375774,"eighty":-1.255424,"marketCap":2877274835},{"date":"2022-08-05","current":-1.372635,"twenty":-4.347615,"median":-1.371808,"eighty":-1.256374,"marketCap":2884292578},{"date":"2022-08-12","current":-1.280717,"twenty":-4.343959,"median":-1.369947,"eighty":-1.257543,"marketCap":2694813504},{"date":"2022-08-19","current":-1.206073,"twenty":-4.332903,"median":-1.367474,"eighty":-1.255424,"marketCap":2512352173},{"date":"2022-08-26","current":-1.419225,"twenty":-4.321575,"median":-1.369256,"eighty":-1.256374,"marketCap":2680778017},{"date":"2022-09-02","current":-1.491454,"twenty":-4.281721,"median":-1.37074,"eighty":-1.257543,"marketCap":2807097400},{"date":"2022-09-09","current":-1.459725,"twenty":-4.23912,"median":-1.374053,"eighty":-1.260033,"marketCap":2736919965},{"date":"2022-09-16","current":-1.23156,"twenty":-4.15674,"median":-1.374053,"eighty":-1.25723,"marketCap":2287784381},{"date":"2022-09-23","current":-1.271072,"twenty":-4.015774,"median":-1.37074,"eighty":-1.252549,"marketCap":2315855355},{"date":"2022-09-30","current":-1.195605,"twenty":-3.959398,"median":-1.369256,"eighty":-1.248765,"marketCap":2182518228},{"date":"2022-10-07","current":-1.191829,"twenty":-3.930612,"median":-1.367396,"eighty":-1.240217,"marketCap":2175500485},{"date":"2022-10-14","current":-1.32118,"twenty":-3.830419,"median":-1.367209,"eighty":-1.23903,"marketCap":2386032790},{"date":"2022-10-21","current":-1.142485,"twenty":-3.821978,"median":-1.363715,"eighty":-1.234955,"marketCap":2049181102},{"date":"2022-10-28","current":-1.026865,"twenty":-3.816338,"median":-1.357179,"eighty":-1.231371,"marketCap":1838648797},{"date":"2022-11-04","current":-1.114008,"twenty":-3.815823,"median":-1.342128,"eighty":-1.206878,"marketCap":2014092384},{"date":"2022-11-11","current":-1.342699,"twenty":-3.788983,"median":-1.336938,"eighty":-1.206878,"marketCap":2449192481},{"date":"2022-11-18","current":-1.351175,"twenty":-3.649857,"median":-1.338707,"eighty":-1.21324,"marketCap":2456210225},{"date":"2022-11-25","current":-1.358089,"twenty":-3.463579,"median":-1.335946,"eighty":-1.226609,"marketCap":2449192481},{"date":"2022-12-02","current":-1.419205,"twenty":-3.205834,"median":-1.341074,"eighty":-1.230134,"marketCap":2603582838},{"date":"2022-12-09","current":-1.425095,"twenty":-3.091661,"median":-1.342584,"eighty":-1.231371,"marketCap":2638671556},{"date":"2022-12-16","current":-1.344849,"twenty":-3.079858,"median":-1.344625,"eighty":-1.231842,"marketCap":2484281199},{"date":"2022-12-23","current":-1.177326,"twenty":-3.046735,"median":-1.342584,"eighty":-1.226609,"marketCap":2175500485},{"date":"2022-12-30","current":-1.204469,"twenty":-3.015207,"median":-1.341074,"eighty":-1.207841,"marketCap":2252695663},{"date":"2023-01-06","current":-1.106797,"twenty":-2.987775,"median":-1.336442,"eighty":-1.204712,"marketCap":2091287563},{"date":"2023-01-13","current":-1.089671,"twenty":-2.971503,"median":-1.334558,"eighty":-1.199182,"marketCap":2098305306},{"date":"2023-01-20","current":-1.124834,"twenty":-2.954945,"median":-1.333335,"eighty":-1.195449,"marketCap":2147429511},{"date":"2023-01-27","current":-1.087852,"twenty":-2.946123,"median":-1.332603,"eighty":-1.194704,"marketCap":2077252076},{"date":"2023-02-03","current":-1.188278,"twenty":-2.933064,"median":-1.331842,"eighty":-1.192669,"marketCap":2280766637},{"date":"2023-02-10","current":-1.287421,"twenty":-1.525941,"median":-1.328971,"eighty":-1.193989,"marketCap":2456210225},{"date":"2023-02-17","current":-1.281147,"twenty":-1.50531,"median":-1.328646,"eighty":-1.194704,"marketCap":2421121507},{"date":"2023-02-24","current":-1.172942,"twenty":-1.494313,"median":-1.326882,"eighty":-1.194704,"marketCap":2189535972},{"date":"2023-03-03","current":-1.157957,"twenty":-1.493734,"median":-1.321415,"eighty":-1.191829,"marketCap":2175500485},{"date":"2023-03-10","current":-1.211725,"twenty":-1.190652,"median":-1.159041,"eighty":-1.126108,"marketCap":2259713407},{"date":"2023-03-17","current":-3.757269,"twenty":-5.774798,"median":-1.344849,"eighty":-1.195881,"marketCap":2119358537},{"date":"2023-03-24","current":-3.296419,"twenty":-5.768235,"median":-1.346683,"eighty":-1.196353,"marketCap":1880755258},{"date":"2023-03-31","current":-3.65645,"twenty":-5.686352,"median":-1.351175,"eighty":-1.196881,"marketCap":2070234332},{"date":"2023-04-06","current":-3.79524,"twenty":-5.576691,"median":-1.354699,"eighty":-1.197545,"marketCap":2147429511},{"date":"2023-04-14","current":-3.717153,"twenty":-5.572353,"median":-1.357634,"eighty":-1.198435,"marketCap":2105323050},{"date":"2023-04-21","current":-3.570303,"twenty":-5.57104,"median":-1.361622,"eighty":-1.199356,"marketCap":2021110128},{"date":"2023-04-28","current":-3.399211,"twenty":-5.544018,"median":-1.366786,"eighty":-1.200488,"marketCap":1909928659},{"date":"2023-05-05","current":-1.47972,"twenty":-5.113983,"median":-1.367306,"eighty":-1.200742,"marketCap":1806339308},{"date":"2023-05-12","current":-1.457938,"twenty":-4.816469,"median":-1.368747,"eighty":-1.202979,"marketCap":1767493302},{"date":"2023-05-19","current":-1.467897,"twenty":-4.53297,"median":-1.370434,"eighty":-1.204467,"marketCap":1754544633},{"date":"2023-05-25","current":-1.457646,"twenty":-4.350068,"median":-1.372221,"eighty":-1.204631,"marketCap":1735121629},{"date":"2023-06-02","current":-1.462605,"twenty":-4.348078,"median":-1.376078,"eighty":-1.205206,"marketCap":1735121629},{"date":"2023-06-09","current":-1.502976,"twenty":-4.34487,"median":-1.378591,"eighty":-1.205852,"marketCap":1780441971},{"date":"2023-06-16","current":-1.510209,"twenty":-4.335981,"median":-1.40341,"eighty":-1.206957,"marketCap":1780441971},{"date":"2023-06-23","current":-1.48536,"twenty":-4.325022,"median":-1.411271,"eighty":-1.208646,"marketCap":1741595964},{"date":"2023-06-30","current":-1.493347,"twenty":-4.305992,"median":-1.416252,"eighty":-1.210425,"marketCap":1735121629},{"date":"2023-07-07","current":-1.4851,"twenty":-4.251341,"median":-1.419225,"eighty":-1.212479,"marketCap":1722172961},{"date":"2023-07-14","current":-1.443472,"twenty":-4.191819,"median":-1.424435,"eighty":-1.217475,"marketCap":1697389123},{"date":"2023-07-21","current":-1.455748,"twenty":-4.033638,"median":-1.428761,"eighty":-1.225478,"marketCap":1703867707},{"date":"2023-07-28","current":-1.57367,"twenty":-3.960791,"median":-1.43135,"eighty":-1.226609,"marketCap":1839917980},{"date":"2023-08-04","current":-1.510208,"twenty":-3.950465,"median":-1.43932,"eighty":-1.230134,"marketCap":1768653552},{"date":"2023-08-11","current":-1.490967,"twenty":-3.911595,"median":-1.44369,"eighty":-1.231371,"marketCap":1736260629},{"date":"2023-08-18","current":-3.132942,"twenty":-3.830419,"median":-1.444644,"eighty":-1.231842,"marketCap":1626124694},{"date":"2023-08-25","current":-2.969212,"twenty":-3.821978,"median":-1.445275,"eighty":-1.233024,"marketCap":1541903096},{"date":"2023-09-01","current":-2.956935,"twenty":-3.816338,"median":-1.446182,"eighty":-1.233589,"marketCap":1541903096},{"date":"2023-09-08","current":-3.004733,"twenty":-3.815823,"median":-1.448334,"eighty":-1.234955,"marketCap":1548381681},{"date":"2023-09-15","current":-3.01904,"twenty":-3.811615,"median":-1.451164,"eighty":-1.235394,"marketCap":1567817434},{"date":"2023-09-22","current":-2.85831,"twenty":-3.787646,"median":-1.455328,"eighty":-1.237379,"marketCap":1477858669},{"date":"2023-09-29","current":-3.059687,"twenty":-3.751278,"median":-1.457646,"eighty":-1.23903,"marketCap":1584691826},{"date":"2023-10-06","current":-3.026759,"twenty":-3.727312,"median":-1.458125,"eighty":-1.23906,"marketCap":1566886300},{"date":"2023-10-13","current":-3.077215,"twenty":-3.723642,"median":-1.459629,"eighty":-1.244992,"marketCap":1590627001},{"date":"2023-10-20","current":-3.058964,"twenty":-3.720543,"median":-1.462605,"eighty":-1.24512,"marketCap":1578756651},{"date":"2023-10-27","current":-2.991248,"twenty":-3.717831,"median":-1.465035,"eighty":-1.246735,"marketCap":1543145598},{"date":"2023-11-03","current":-3.545569,"twenty":-3.717153,"median":-1.467897,"eighty":-1.247319,"marketCap":1833969192},{"date":"2023-11-10","current":-4.143101,"twenty":-3.733303,"median":-1.474061,"eighty":-1.248161,"marketCap":2142598312},{"date":"2023-11-17","current":-4.037822,"twenty":-3.815973,"median":-1.480171,"eighty":-1.24945,"marketCap":2106987259},{"date":"2023-11-24","current":-4.106384,"twenty":-3.936201,"median":-1.481481,"eighty":-1.250638,"marketCap":2160403838},{"date":"2023-12-01","current":-4.785978,"twenty":-3.975325,"median":-1.482715,"eighty":-1.251161,"marketCap":2528384711},{"date":"2023-12-08","current":-3.891697,"twenty":-4.03647,"median":-1.4851,"eighty":-1.251909,"marketCap":2047635506},{"date":"2023-12-15","current":-4.22825,"twenty":-4.04732,"median":-1.485381,"eighty":-1.254031,"marketCap":2237561118},{"date":"2023-12-22","current":-3.928054,"twenty":-4.053689,"median":-1.486481,"eighty":-1.255725,"marketCap":2077311383},{"date":"2023-12-29","current":-4.074674,"twenty":-4.058065,"median":-1.490204,"eighty":-1.256258,"marketCap":2166339013},{"date":"2024-01-05","current":-3.788817,"twenty":-4.056443,"median":-1.492272,"eighty":-1.256918,"marketCap":2000154103},{"date":"2024-01-12","current":-3.483407,"twenty":-4.05084,"median":-1.493347,"eighty":-1.258339,"marketCap":1839904367},{"date":"2024-01-19","current":-2.914334,"twenty":-4.047812,"median":-1.494832,"eighty":-1.259474,"marketCap":1537210423},{"date":"2024-01-26","current":-2.880535,"twenty":-4.044627,"median":-1.497595,"eighty":-1.261418,"marketCap":1513469721},{"date":"2024-02-02","current":-2.567515,"twenty":-4.037992,"median":-1.4988,"eighty":-1.262107,"marketCap":1347284811},{"date":"2024-02-09","current":-2.509912,"twenty":-4.037484,"median":-1.499599,"eighty":-1.26303,"marketCap":1323544109},{"date":"2024-02-16","current":-2.700667,"twenty":-4.03647,"median":-1.502976,"eighty":-1.264369,"marketCap":1424442091},{"date":"2024-02-23","current":-2.873353,"twenty":-4.026782,"median":-1.50531,"eighty":-1.265853,"marketCap":1507534546},{"date":"2024-03-01","current":-3.007226,"twenty":-4.016267,"median":-1.510715,"eighty":-1.267104,"marketCap":1578756651},{"date":"2024-03-08","current":-2.994589,"twenty":-4.004209,"median":-1.514033,"eighty":-1.267614,"marketCap":1572821475},{"date":"2024-03-15","current":-3.717992,"twenty":-3.994485,"median":-1.516618,"eighty":-1.270393,"marketCap":1744815141},{"date":"2024-03-22","current":-3.564943,"twenty":-3.976958,"median":-1.519285,"eighty":-1.272911,"marketCap":1671460637},{"date":"2024-03-28","current":-3.64693,"twenty":-3.970449,"median":-1.523269,"eighty":-1.274866,"marketCap":1704431629},{"date":"2024-04-05","current":-3.527526,"twenty":-3.967421,"median":-1.525007,"eighty":-1.27673,"marketCap":1647541141},{"date":"2024-04-12","current":-3.689898,"twenty":-3.961738,"median":-1.534783,"eighty":-1.2803,"marketCap":1724356386},{"date":"2024-04-19","current":-3.642953,"twenty":-3.959005,"median":-1.540073,"eighty":-1.280803,"marketCap":1700964660},{"date":"2024-04-26","current":-4.107449,"twenty":-3.959005,"median":-1.565243,"eighty":-1.281169,"marketCap":1915482404},{"date":"2024-05-03","current":-4.976884,"twenty":-3.973027,"median":-1.58912,"eighty":-1.281256,"marketCap":2319333229},{"date":"2024-05-10","current":-4.784327,"twenty":-4.024444,"median":-1.91607,"eighty":-1.283533,"marketCap":2234890831},{"date":"2024-05-17","current":-5.194111,"twenty":-4.039682,"median":-2.183001,"eighty":-1.285137,"marketCap":2422751220},{"date":"2024-05-24","current":-4.64921,"twenty":-4.058631,"median":-2.509912,"eighty":-1.28634,"marketCap":2163633442},{"date":"2024-05-31","current":-4.402153,"twenty":-4.106597,"median":-2.550052,"eighty":-1.287245,"marketCap":2050744147},{"date":"2024-06-07","current":-4.13551,"twenty":-4.133471,"median":-2.567515,"eighty":-1.289289,"marketCap":1924139578},{"date":"2024-06-14","current":-4.2508,"twenty":-4.138546,"median":-2.642702,"eighty":-1.289956,"marketCap":1975968254},{"date":"2024-06-21","current":-4.357482,"twenty":-4.155859,"median":-2.683175,"eighty":-1.29202,"marketCap":2021318345},{"date":"2024-06-28","current":-4.540926,"twenty":-4.178794,"median":-2.709261,"eighty":-1.293725,"marketCap":2105539943},{"date":"2024-07-05","current":-4.513963,"twenty":-4.22771,"median":-2.729604,"eighty":-1.294301,"marketCap":2092582774},{"date":"2024-07-12","current":-4.397187,"twenty":-4.243592,"median":-2.759528,"eighty":-1.295064,"marketCap":2041442184},{"date":"2024-07-19","current":-4.220132,"twenty":-4.246463,"median":-2.788193,"eighty":-1.295793,"marketCap":1959278876},{"date":"2024-07-26","current":-4.068882,"twenty":-4.243592,"median":-2.838066,"eighty":-1.296674,"marketCap":1896076332},{"date":"2024-08-02","current":-3.881262,"twenty":-4.234933,"median":-2.853417,"eighty":-1.299007,"marketCap":1807592769},{"date":"2024-08-09","current":-4.030819,"twenty":-4.22771,"median":-2.876944,"eighty":-1.303142,"marketCap":1889756077},{"date":"2024-08-16","current":-110.215085,"twenty":-4.243592,"median":-2.92186,"eighty":-1.305862,"marketCap":1940318113},{"date":"2024-08-23","current":-110.378813,"twenty":-4.25597,"median":-2.932478,"eighty":-1.306376,"marketCap":1951413621},{"date":"2024-08-30","current":-111.169888,"twenty":-4.272942,"median":-2.946123,"eighty":-1.307217,"marketCap":1978593894},{"date":"2024-09-06","current":-112.071186,"twenty":-4.323518,"median":-2.954611,"eighty":-1.307853,"marketCap":1995595657},{"date":"2024-09-13","current":-101.344705,"twenty":-4.348078,"median":-2.964171,"eighty":-1.30892,"marketCap":1799870769},{"date":"2024-09-20","current":-109.898813,"twenty":-4.365964,"median":-2.968177,"eighty":-1.311188,"marketCap":1963495385},{"date":"2024-09-27","current":-119.045575,"twenty":-4.40116,"median":-2.97652,"eighty":-1.316813,"marketCap":2139706509},{"date":"2024-10-04","current":-139.784796,"twenty":-4.434604,"median":-2.983036,"eighty":-1.317658,"marketCap":2501057776},{"date":"2024-10-10","current":-121.076225,"twenty":-4.514518,"median":-2.991277,"eighty":-1.318017,"marketCap":2152293018},{"date":"2024-10-18","current":-136.483117,"twenty":-4.546226,"median":-2.994589,"eighty":-1.318181,"marketCap":2413520753},{"date":"2024-10-25","current":-148.160756,"twenty":-4.649306,"median":-3.00209,"eighty":-1.320584,"marketCap":2619858020},{"date":"2024-11-01","current":-152.301356,"twenty":-4.729636,"median":-3.007226,"eighty":-1.321368,"marketCap":2694889753},{"date":"2024-11-08","current":-175.184116,"twenty":-4.749387,"median":-3.020226,"eighty":-1.321799,"marketCap":3076301064},{"date":"2024-11-15","current":-156.067929,"twenty":-4.801593,"median":-3.026759,"eighty":-1.324719,"marketCap":2719900331},{"date":"2024-11-22","current":-150.055075,"twenty":-4.857642,"median":-3.029314,"eighty":-1.327756,"marketCap":2613605375},{"date":"2024-11-29","current":-166.303938,"twenty":-5.049525,"median":-3.046032,"eighty":-1.328549,"marketCap":2894974375},{"date":"2024-12-06","current":-174.977402,"twenty":-5.544018,"median":-3.050955,"eighty":-1.328637,"marketCap":3038785197},{"date":"2024-12-13","current":-157.839535,"twenty":-5.762384,"median":-3.054687,"eighty":-1.328715,"marketCap":2738658264},{"date":"2024-12-20","current":-157.261391,"twenty":-5.81235,"median":-3.05764,"eighty":-1.328813,"marketCap":2713647686},{"date":"2024-12-27","current":-161.735106,"twenty":-5.918405,"median":-3.058964,"eighty":-1.328943,"marketCap":2788679420},{"date":"2025-01-03","current":-161.576912,"twenty":-6.262403,"median":-3.0609,"eighty":-1.329656,"marketCap":2788679420},{"date":"2025-01-10","current":-160.009513,"twenty":-6.505115,"median":-3.073313,"eighty":-1.331919,"marketCap":2751163553},{"date":"2025-01-17","current":-163.8775,"twenty":-6.673144,"median":-3.085511,"eighty":-1.33225,"marketCap":2819942642},{"date":"2025-01-24","current":-170.801291,"twenty":-6.744567,"median":-3.092579,"eighty":-1.33245,"marketCap":2957500820},{"date":"2025-01-28","current":-173.143828,"twenty":-6.751024,"median":-3.096083,"eighty":-1.332653,"marketCap":3013774620},{"date":"2025-02-07","current":-175.935342,"twenty":-6.827912,"median":-3.103292,"eighty":-1.333431,"marketCap":3045037842},{"date":"2025-02-14","current":-180.702049,"twenty":-6.966007,"median":-3.137967,"eighty":-1.333994,"marketCap":3120069575},{"date":"2025-02-21","current":-234.099528,"twenty":-7.122579,"median":-3.157846,"eighty":-1.33438,"marketCap":4064218886},{"date":"2025-02-28","current":-217.890434,"twenty":-7.428225,"median":-3.248798,"eighty":-1.334681,"marketCap":3770344597},{"date":"2025-03-07","current":156.564078,"twenty":-7.428225,"median":-3.233993,"eighty":-1.333431,"marketCap":4752009774},{"date":"2025-03-14","current":163.096911,"twenty":-7.421807,"median":-3.143712,"eighty":-1.330749,"marketCap":4952094396},{"date":"2025-03-21","current":162.954964,"twenty":-7.419231,"median":-3.12686,"eighty":-1.328628,"marketCap":4945841752},{"date":"2025-03-28","current":176.290417,"twenty":-7.24304,"median":-3.099502,"eighty":-1.321703,"marketCap":5339758351},{"date":"2025-04-03","current":161.577767,"twenty":-7.123902,"median":-3.092579,"eighty":-1.318144,"marketCap":4895820596},{"date":"2025-04-11","current":142.214826,"twenty":-7.086528,"median":-3.085511,"eighty":-1.30892,"marketCap":4270556152},{"date":"2025-04-17","current":142.082188,"twenty":-7.03615,"median":-3.077215,"eighty":-1.30617,"marketCap":4276808796},{"date":"2025-04-25","current":157.525338,"twenty":-7.035077,"median":-3.06483,"eighty":-1.297429,"marketCap":4745757129},{"date":"2025-05-02","current":164.646937,"twenty":-6.98082,"median":-3.059687,"eighty":-1.294598,"marketCap":4970852329},{"date":"2025-05-09","current":160.887021,"twenty":-6.966007,"median":-3.058035,"eighty":-1.289956,"marketCap":4891435796},{"date":"2025-05-16","current":166.920406,"twenty":-6.956944,"median":-3.054843,"eighty":-1.284736,"marketCap":5116329396},{"date":"2025-05-23","current":172.811396,"twenty":-6.918805,"median":-3.051744,"eighty":-1.280509,"marketCap":5312740129},{"date":"2025-05-30","current":194.14447,"twenty":-6.859825,"median":-3.047185,"eighty":-1.269715,"marketCap":5994823373},{"date":"2025-06-06","current":193.852557,"twenty":-6.827912,"median":-3.029734,"eighty":-1.263923,"marketCap":6001081017},{"date":"2025-06-13","current":206.909864,"twenty":-6.817054,"median":-3.027014,"eighty":-1.258681,"marketCap":6407827906},{"date":"2025-06-20","current":226.129725,"twenty":-6.80981,"median":-3.021411,"eighty":-1.253542,"marketCap":6989324733},{"date":"2025-06-27","current":219.382855,"twenty":-6.774951,"median":-3.010594,"eighty":-1.249178,"marketCap":6799778035},{"date":"2025-07-04","current":207.131321,"twenty":-6.751721,"median":-3.004715,"eighty":-1.245928,"marketCap":6420343195},{"date":"2025-07-11","current":194.227376,"twenty":-6.748553,"median":-2.997106,"eighty":-1.23779,"marketCap":6014301773},{"date":"2025-07-18","current":239.206864,"twenty":-6.742193,"median":-2.992401,"eighty":-1.233081,"marketCap":7401298850},{"date":"2025-07-25","current":223.606361,"twenty":-6.733962,"median":-2.987644,"eighty":-1.227416,"marketCap":6943764012},{"date":"2025-08-01","current":221.508288,"twenty":-6.720681,"median":-2.97652,"eighty":-1.21075,"marketCap":6836108756},{"date":"2025-08-08","current":50.470458,"twenty":-6.69485,"median":-2.968177,"eighty":-1.205206,"marketCap":8274964605},{"date":"2025-08-15","current":65.75115,"twenty":-6.664055,"median":-2.960553,"eighty":-1.200737,"marketCap":10764181600},{"date":"2025-08-22","current":69.328024,"twenty":-6.623327,"median":-2.952385,"eighty":-1.196881,"marketCap":11314163907},{"date":"2025-08-29","current":70.197956,"twenty":-6.58783,"median":-2.944688,"eighty":-1.195394,"marketCap":11510826312},{"date":"2025-09-05","current":74.741403,"twenty":-6.545813,"median":-2.931892,"eighty":-1.193197,"marketCap":12243700183},{"date":"2025-09-12","current":74.279336,"twenty":-6.493001,"median":-2.918097,"eighty":-1.190811,"marketCap":12189911275},{"date":"2025-09-19","current":71.544121,"twenty":-6.455769,"median":-2.873353,"eighty":-1.179252,"marketCap":11732705557},{"date":"2025-09-26","current":69.674923,"twenty":-6.40006,"median":-2.852194,"eighty":-1.166431,"marketCap":11396524882},{"date":"2025-10-03","current":74.307,"twenty":-6.312512,"median":-2.838066,"eighty":-1.159178,"marketCap":12183187662},{"date":"2025-10-10","current":70.431829,"twenty":-6.288573,"median":-2.801814,"eighty":-1.154706,"marketCap":11530997152},{"date":"2025-10-17","current":63.17088,"twenty":-6.157723,"median":-2.769702,"eighty":-1.141961,"marketCap":10334193949},{"date":"2025-10-24","current":58.25878,"twenty":-5.928147,"median":-2.735891,"eighty":-1.138284,"marketCap":9534083943},{"date":"2025-10-31","current":59.730926,"twenty":-5.921366,"median":-2.711752,"eighty":-1.135193,"marketCap":9789581256},{"date":"2025-11-07","current":58.126276,"twenty":-5.917138,"median":-2.68435,"eighty":-1.120838,"marketCap":9520636716},{"date":"2025-11-14","current":60.172448,"twenty":-5.914987,"median":-2.645577,"eighty":-1.113983,"marketCap":9883711845},{"date":"2025-11-21","current":53.525201,"twenty":-5.81235,"median":-2.567515,"eighty":-1.103539,"marketCap":8787762844},{"date":"2025-11-28","current":58.350437,"twenty":-5.778066,"median":-2.550052,"eighty":-1.098391,"marketCap":9614767305},{"date":"2025-12-05","current":57.842944,"twenty":-5.775395,"median":-2.509912,"eighty":-1.092946,"marketCap":9547531170},{"date":"2025-12-12","current":58.224062,"twenty":-5.774323,"median":-2.183001,"eighty":-1.08917,"marketCap":9628214532},{"date":"2025-12-19","current":54.679817,"twenty":-5.762384,"median":-1.913119,"eighty":-1.074189,"marketCap":9063430998},{"date":"2025-12-24","current":54.10565,"twenty":-5.686352,"median":-1.597844,"eighty":-1.065407,"marketCap":8996194863},{"date":"2026-01-02","current":52.443492,"twenty":-5.575606,"median":-1.569456,"eighty":-1.038831,"marketCap":8754144777},{"date":"2026-01-09","current":57.857956,"twenty":-5.571211,"median":-1.54358,"eighty":49.652014,"marketCap":9682003440},{"date":"2026-01-16","current":58.071036,"twenty":-5.564242,"median":-1.534833,"eighty":52.436859,"marketCap":9749239575},{"date":"2026-01-23","current":55.601293,"twenty":-5.468644,"median":-1.525941,"eighty":53.637621,"marketCap":9325651924},{"date":"2026-01-30","current":49.88128,"twenty":-5.183001,"median":-1.52299,"eighty":53.637621,"marketCap":8404516875},{"date":"2026-02-06","current":50.312337,"twenty":-5.136266,"median":-1.517963,"eighty":53.524919,"marketCap":8498647464},{"date":"2026-02-13","current":50.856111,"twenty":-5.107703,"median":-1.515573,"eighty":53.489701,"marketCap":8639843347},{"date":"2026-02-20","current":52.277019,"twenty":-5.068918,"median":-1.514739,"eighty":53.421518,"marketCap":8868446206},{"date":"2026-02-27","current":49.828129,"twenty":-4.998183,"median":-1.511222,"eighty":53.106998,"marketCap":8545712758},{"date":"2026-03-06","current":127.465929,"twenty":-4.960983,"median":-1.507759,"eighty":53.421518,"marketCap":7987652838},{"date":"2026-03-13","current":129.444808,"twenty":-4.904282,"median":-1.502976,"eighty":53.76928,"marketCap":8149019562},{"date":"2026-03-18","current":133.533929,"twenty":-4.869572,"median":-1.501288,"eighty":54.371907,"marketCap":8411240488}],"updateTime":1773943983233},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02256\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620299991","title":"和譽-B(02256)：FGFR2/3抑制劑ABSK061 獲FDA授予孤兒藥資格認定 用於治療軟骨發育不全","url":"https://stock-news.laohu8.com/highlight/detail?id=2620299991","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620299991?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 08:16","pubTimestamp":1773879410,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B 发布公告，本公司的附属公司上海和誉生物医药科技有限公司宣布，其自主研发的高选择性口服小分子FGFR2/3抑制剂ABSK061已获得美国食品药品监督管理局授予的孤儿药资格认定，用于治疗软骨发育不全。这是ABSK061近期获得FDA授予罕见儿科疾病资格认定后，在其全球开发进程中的又一关键里程碑。ABSK061用于治疗软骨发育不全已获得FDA授予的RPD和ODD认定，II期临床试验正在推进中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2476274720.SGD","LU2488822045.USD","02256","LU2778985437.USD","LU2476274308.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","BK4585","IE00B543WZ88.USD","BK4588","LABU"],"gpt_icon":0},{"id":"2619481780","title":"和譽-B(02256)：依帕戈替尼聯合靶免療法一線治療晚期肝細胞癌完成 II期臨床首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2619481780","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619481780?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 08:14","pubTimestamp":1773620062,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B 发布公告，本公司的附属公司上海和誉生物医药科技有限公司宣布，其自主研发的高选择性口服小分子FGFR4抑制剂依帕戈替尼联合标准疗法，已在针对晚期或不可切除肝细胞癌一线治疗的II期临床研究中完成首例患者给药。在2025年欧洲肿瘤内科学会胃肠道肿瘤大会上，和誉医药公布了依帕戈替尼联合阿替利珠单抗治疗HCC的II 期研究结果。除单药治疗之外，和誉医药同时在探索依帕戈替尼联合抗PD-L1抗体的II期试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B(02256)：依帕戈替尼联合靶免疗法一线治疗晚期肝细胞癌完成 II期临床首例患者给药","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2476274308.USD","BK1161","LU2488822045.USD","02256","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2778985437.USD","LU2476274720.SGD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2618909166","title":"和譽－Ｂ(02256)股價下跌5.11%，現價港幣$12.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2618909166","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618909166?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 11:05","pubTimestamp":1773284700,"startTime":"0","endTime":"0","summary":"[下跌股]和誉－Ｂ(02256) 股价在上午11:05比前收市价下跌5.11%，现股价为港币$12.07。至目前为止，今日最高价为$12.77，而最低价为$12.07。总成交量为64.3万股，总成交金额为港币$796.57万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603121600/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603121600/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2476274308.USD","02256","IE00B5MMRT66.SGD","LU2488822045.USD","IE00B543WZ88.USD","BK1161","IE00BPRC5H50.USD","LU2476274720.SGD","LU2778985437.USD"],"gpt_icon":0},{"id":"2618186911","title":"每日沽空追蹤 | 和譽-B 03月11日沽空量成交6.3萬股，沽空比例為2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618186911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618186911?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 16:30","pubTimestamp":1773217829,"startTime":"0","endTime":"0","summary":"和誉-B北京时间03月11日，跌0.78%，卖空量成交6.3万股，较上一交易日减少75.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163354a460b692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163354a460b692&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","02256","LU2476274720.SGD","LU2488822045.USD","LU2778985437.USD","IE00B5MMRT66.SGD","BK1161","IE00BPRC5H50.USD","LU2476274308.USD"],"gpt_icon":0},{"id":"2618924186","title":"和譽-B03月11日主力淨流出177.5萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618924186","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618924186?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 16:16","pubTimestamp":1773216962,"startTime":"0","endTime":"0","summary":"03月11日, 和誉-B股价跌0.78%，报收12.72元，成交金额3285.1万元，换手率0.38%，振幅5.69%，量比1.09。和誉-B今日主力资金净流出177.5万元，上一交易日主力净流入199.8万元。该股近5个交易日上涨16.33%，主力资金累计净流入4.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出205.0万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162138a460ac70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162138a460ac70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","IE00BPRC5H50.USD","LU2778985437.USD","IE00B543WZ88.USD","02256","LU2488822045.USD","LU2476274308.USD","LU2476274720.SGD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2618931689","title":"和譽(02256.HK)用於治療軟骨發育不全藥品ABSK061獲藥物資格認定","url":"https://stock-news.laohu8.com/highlight/detail?id=2618931689","media":"阿斯达克财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618931689?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 08:44","pubTimestamp":1773189840,"startTime":"0","endTime":"0","summary":"和誉-B(02256.HK) 公布，其自主研发的高选择性、口服小分子FGFR2/3抑制剂ABSK061，已获得美国食品药品监督管理局(FDA)授予用于治疗软骨发育不全(ACH)的罕见儿科疾病(Rare Pediatric Disease，RPD)药物资格认定。(ca/w)(港股报价延迟最少十五分钟。沽空资料截至 2026-03-10 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211028115122826_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211028115122826_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1508159/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1508159/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00B5MMRT66.SGD","IE00BPRC5H50.USD","IE00B543WZ88.USD","BK1161","LU2476274720.SGD","LU2488822045.USD","LU2778985437.USD","LU2476274308.USD","02256"],"gpt_icon":0},{"id":"2618998304","title":"和譽-B(02256)：FGFR2/3抑制劑ABSK061獲FDA授予罕見兒科疾病藥物資格認定","url":"https://stock-news.laohu8.com/highlight/detail?id=2618998304","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618998304?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 08:14","pubTimestamp":1773188070,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B 发布公告，公司的附属公司上海和誉生物医药科技有限公司宣布，其自主研发的高选择性、口服小分子FGFR2/3抑制剂ABSK061，已获得美国食品药品监督管理局授予用于治疗软骨发育不全的罕见儿科疾病药物资格认定。其口服给药方式在便捷性和治疗依从性方面具有显著优势，尤其对儿科患者而言，这使得ABSK061有望成为治疗儿童和青少年ACH患者的具有潜在价值的治疗候选药物。目前，ABSK061正在开展针对3-12岁儿童ACH患者的II期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU2476274308.USD","BK1161","LU2488822045.USD","02256","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK4585","LU2778985437.USD","LU2476274720.SGD","LABU","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2618985985","title":"港股異動 | 和譽-B(02256)再升逾9% 貝捷邁全球III期MANEUVER研究結果榮登《柳葉刀》","url":"https://stock-news.laohu8.com/highlight/detail?id=2618985985","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618985985?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 13:36","pubTimestamp":1773121010,"startTime":"0","endTime":"0","summary":"和誉-B(02256)再涨超9%，截至发稿，涨8.76%，报12.91港元，成交额2199.69万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260310/20260310133720_71529.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260310/20260310133720_71529.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2778985437.USD","III","VXUS","LU2488822045.USD","IE00B5MMRT66.SGD","LU2476274308.USD","LU2476274720.SGD","BK4134","IE00B543WZ88.USD","BK1161","BK4588","02256","IE00BPRC5H50.USD","BK4585"],"gpt_icon":0},{"id":"1103606349","title":"異動解讀 | 利好出盡，和譽-B盤中大跌6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103606349","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103606349?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 09:37","pubTimestamp":1773020231,"startTime":"0","endTime":"0","summary":"和誉-B(02256)今日盘中股价大幅下挫6.14%，引发市场关注。消息面上，公司近期发布了其核心产品贝捷迈®(盐酸匹米替尼胶囊，ABSK021)全球III期MANEUVER研究的积极结果，该结果已于国际顶级医学期刊《柳叶刀》正式发表，标志着该创新疗法获得了重要的国际学术认可。然而，市场似乎对此利好采取了“卖出事实”的反应。分析认为，尽管该研究数据优异，显示药物在治疗腱鞘巨细胞瘤方面具有显著疗效和良好安全性，且其新药上市申请已获美国FDA受理，但在重大利好消息正式公布后，部分投资者选择获利了结，导致了股价的短期回调。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02256"],"gpt_icon":0},{"id":"2618692617","title":"和譽-B(02256)：《柳葉刀》(The Lancet)發布貝捷邁®全球III期MANEUVER研究結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2618692617","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618692617?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 08:03","pubTimestamp":1773014618,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，公司的附属公司上海和誉生物医药科技有限公司(和誉医药)宣布，其自主研发的新型、口服、高选择性且高效的小分子CSF-1R抑制剂贝捷迈®(盐酸匹米替尼胶囊，ABSK021)的全球多中心III期MANEUVER研究结果，于3月5日(西欧时间)正式发表于国际医学期刊《柳叶刀》 (The Lancet)1。此次发表标志着和誉医药这一创新疗法在临床研究质量、数据完整性及国际学术认可度方面取得了重要里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","BK1161","LU2778985437.USD","02256","LU2476274308.USD","LU2476274720.SGD","BK4134","LU2488822045.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"1114090662","title":"和譽-B（02256）2026年2月股份變動月報：股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1114090662","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114090662?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 16:40","pubTimestamp":1772700043,"startTime":"0","endTime":"0","summary":"和誉开曼有限责任公司于2026年3月5日发布截至2026年2月28日的股份变动月报。公告显示，公司本月无新增发行及注销，股本总体维持稳定。已发行股份及库存股份亦无变化。截至2月底，公司已发行股份总数为672,361,350股，库存股份为7,744,000股，合计680,105,350股，维持与上月相同。在股份期权与激励计划方面，公司2021年9月16日经股东大会批准的首次公开发售后购股权计划共授出9,764,758份期权，报告期内无新增发行或自库存股份转让。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"gpt_icon":0},{"id":"2617543239","title":"每日沽空追蹤 | 和譽-B 03月05日沽空量成交7.8萬股，沽空比例為3.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617543239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617543239?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 16:30","pubTimestamp":1772699429,"startTime":"0","endTime":"0","summary":"和誉-B北京时间03月05日，涨2.9%，卖空量成交7.8万股，较上一交易日减少86.76%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163345a6a5d8d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163345a6a5d8d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2476274720.SGD","LU2488822045.USD","IE00BPRC5H50.USD","02256","LU2778985437.USD","IE00B543WZ88.USD","LU2476274308.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2617459410","title":"和譽-B午前漲逾5% 公司連續第二年實現盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2617459410","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617459410?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 11:51","pubTimestamp":1772682660,"startTime":"0","endTime":"0","summary":"　　和誉-B盘中涨超6%，截至发稿，股价上涨4.90%，现报11.56港元，成交额1602.54万港元。　　近日，和誉-B发布截至2025年12月31日止年度的年度业绩，该集团取得收入6.12亿元，同比增长21.45%；母公司拥有人应占全面收益2369.8万元，同比减少53.46%；每股基本盈利0.09元。集团连续第二年实现盈利。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-03-05/doc-inhpwzrt9953245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BPRC5H50.USD","LU2476274720.SGD","LU2488822045.USD","BK1161","02256","LU2778985437.USD","IE00B5MMRT66.SGD","LU2476274308.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"1151856554","title":"異動解讀 | 和譽-B盤中大漲6.08%，受益於連續盈利及核心產品商業化強勁預期","url":"https://stock-news.laohu8.com/highlight/detail?id=1151856554","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151856554?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 11:21","pubTimestamp":1772680887,"startTime":"0","endTime":"0","summary":"和誉-B今日盘中股价大幅上涨6.08%，引起了市场投资者的关注。消息面上，此次股价波动主要与公司发布的积极年度业绩及核心产品的商业化进展有关。分析指出，在贝捷迈强劲的商业化预期推动下，公司有望步入“创新-变现 - 业绩验证”的新价值循环，为估值持续上行奠定基础，这共同提振了投资者信心，推动了股价在交易时段内的显著上扬。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02256"],"gpt_icon":0},{"id":"2617159659","title":"【券商聚焦】國元證券：港股市場震盪上行，關注創新藥及黃金板塊","url":"https://stock-news.laohu8.com/highlight/detail?id=2617159659","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617159659?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 10:17","pubTimestamp":1772677039,"startTime":"0","endTime":"0","summary":"创新药与黄金板块表现突出，部分个股获机构重点推荐。行业方面，国际金价受央行增持及地缘因素推动持续走强，黄金股如潼关黄金和紫金黄金国际获调入核心组合。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305103653a44da66b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305103653a44da66b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2039709279.SGD","LU0593848301.USD","LU1328277881.USD","SGXZ86797644.SGD","LU0314109678.HKD","SGXZ62798434.SGD","BK1574","HK0000500386.USD","LU0348767384.USD","02256","HK0000252160.HKD","01211","LU0348766576.USD","LU1813983027.USD","HK0000252152.HKD","BK1198","LU2213484517.USD","02259","LU0244354667.USD","06978","02883","LU2543165471.USD","LU0463099449.HKD","BK1161","LU1188198961.HKD","LU0326950275.SGD"],"gpt_icon":1},{"id":"1149722320","title":"異動解讀 | 和譽-B盤中大漲5.83%，KRAS抑制劑臨床試驗獲進展及主席增持提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1149722320","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149722320?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 09:41","pubTimestamp":1772588478,"startTime":"0","endTime":"0","summary":"和誉-B今日盘中股价大幅上涨5.83%，引起了市场的广泛关注。ABSK141是一种针对KRAS G12D突变的高选择性抑制剂，该突变常见于胰腺癌、结直肠癌等多种实体瘤中，目前尚无获批的靶向疗法，因此其临床进展备受关注。同时，徐耀昌博士的增持行为进一步巩固了其持股比例，显示了管理层对公司价值的认可。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02256"],"gpt_icon":0},{"id":"2616303518","title":"和譽-B(02256)：和譽醫藥口服小分子KRAS G12D抑制劑 ABSK141完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2616303518","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616303518?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 08:03","pubTimestamp":1772582585,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，公司的附属公司上海和誉生物医药科技有限公司宣布，其口服、高效、高选择性小分子KRAS G12D抑制剂ABSK141，已在针对携带KRAS G12D突变的晚期实体瘤患者的I/II期临床试验中已成功完成首例患者给药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","IE00B543WZ88.USD","BK1515","159938","BK1574","IE00B5MMRT66.SGD","LU2778985437.USD","02256","09939","IE00BPRC5H50.USD","BK1161","LU2476274720.SGD","LU2476274308.USD"],"gpt_icon":0},{"id":"2616406203","title":"和譽-B(02256)獲創始人、執行董事、首席執行官兼董事會主席徐耀昌增持公司4.5萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616406203","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616406203?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 20:37","pubTimestamp":1772541424,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，公司董事会获本公司创始人、执行董事、首席执行官兼董事会主席徐耀昌博士(徐博士)告知，其已于2026年3月3日于公开市场购买合计4.5万股本公司普通股(股份)，平均价格为每股股份约港币11.26元，占本公司全部已发行股份总数约0.01%。紧随购买后，徐博士于合共81,769,968股股份中拥有权益，占于本公告日期本公司全部已发行股份总数约12.02%。据徐博士告知，其对本集团的业务前景及增长充满信心。在符合适用的法律及监管要求下，徐博士不排除会在适当时候进一步增持本公司股份的可能性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409636.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2476274720.SGD","LU2476274308.USD","IE00BPRC5H50.USD","02256","LU2778985437.USD","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"1109017023","title":"和譽-B首席執行官於公開市場增持4.5萬股，每股均價11.26港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1109017023","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109017023?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 20:36","pubTimestamp":1772541386,"startTime":"0","endTime":"0","summary":"3月3日，和誉-B（股票代码：02256）首席执行官在公开市场进行了股份增持操作，总计购入公司股份45,000股。此次交易的平均价格为每股11.26港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","02256","LU2476274720.SGD","LU2488822045.USD","LU2778985437.USD","IE00B5MMRT66.SGD","BK1161","IE00BPRC5H50.USD","LU2476274308.USD"],"gpt_icon":0},{"id":"1154569389","title":"異動解讀 | 和譽-B盤中大跌5.56%，業績全面收益下滑及高管變動引發市場擔憂","url":"https://stock-news.laohu8.com/highlight/detail?id=1154569389","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154569389?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 09:48","pubTimestamp":1772502486,"startTime":"0","endTime":"0","summary":"和誉-B今日盘中股价大幅下挫5.56%，引起了投资者的广泛关注。消息面上，公司于前一日盘后发布了截至2025年12月31日止年度的年度业绩。尽管报告期内公司收入同比增长21.45%至6.12亿元人民币，且净利润同比大幅增长约95%，但母公司拥有人应占全面收益仅为2369.8万元人民币，同比大幅减少53.46%。市场分析认为，全面收益的显著下滑、缺乏股息派发以及关键管理职位的变动，共同构成了今日股价承压的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02256"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":180,"code":"91000000","status":"200"}]}}